Effectiveness of bisphosphonate for alleviating tinnitus associated with otosclerosis: a prospective case–control study
European Archives of Oto-Rhino-Laryngology · 2025
DOI: 10.1007/s00405-024-08935-z ↗Kurz gefasst
Fachartikel in der Zeitschrift European Archives of Oto-Rhino-Laryngology, 2025. Verfasst von Ayman Fouad und 3 weiteren Autor:innen. Beteiligte Einrichtung: Otolaryngology Department, Faculty of Medicine, Tanta University, El Geish St., Tanta, 31527, Gharbeya, Egypt. ayman88fouad@gmail.com. Hauptthemen laut MEDLINE: Tinnitus, Otosclerosis, Bone Density Conservation Agents, Diphosphonates. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tanta University.
Abstract (Originalsprache)
Purpose
To investigate the short-term efficacy of third-generation bisphosphonate in the management of tinnitus associated with otosclerosis.
Methods
A prospective case–control study included 100 patients with otosclerosis-associated bothersome tinnitus. Patients were assigned to two groups: group A (control): 25 patients who planned to receive only complementary supplements, oral vitamin D plus calcium, and group B (case): 75 patients who planned to receive oral bisphosphonate plus routine vitamin D and calcium supplements. Group B was subdivided into B 1 : 25 patients without any previous intervention, B 2 : 25 patients with persistent tinnitus for more than 6 months after a previous uncomplicated stapedotomy in the same ear, and B 3 : 25 patients with persistent tinnitus for more than 6 months after hearing aid fitting. The outcome was tinnitus assessment both subjectively (tinnitus intensity, frequency, and questionnaire) and objectively (tinnitus intensity and frequency).
Results
The female-to-male ratio was 1.6:1 with ages ranging from 40 to 61 years. The baseline revealed no statistically significant differences between the groups. After 6 months, there were statistically significant differences, both objectively and subjectively. The tinnitus questionnaire median (IQR) for group B was 16 (30), whereas control group A had 52 (24). The tinnitus severity median (IQR) for group B was 20 (30), compared to group A’s 52 (42). After 6 months, 40% of the cases in group B demonstrated complete improvement, compared to 0% in control group A.
Conclusion
We demonstrated significant tinnitus improvement in cases treated with bisphosphonate compared to the control group.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Otolaryngology Department, Faculty of Medicine, Tanta University, El Geish St., Tanta, 31527, Gharbeya, Egypt. ayman88fouad@gmail.com.
- Otolaryngology Department, Faculty of Medicine, Tanta University, El Geish St., Tanta, 31527, Gharbeya, Egypt.
- Otolaryngology Department, Faculty of Medicine, Audiovestibular Unit, Tanta University, Tanta, Egypt.
Förderung
- Tanta University
Zitieren
APA
Fouad, A., Mandour, M., Tomoum, M. O., & Lasheen, R. M. (2025). Effectiveness of bisphosphonate for alleviating tinnitus associated with otosclerosis: a prospective case–control study. European Archives of Oto-Rhino-Laryngology. https://doi.org/10.1007/s00405-024-08935-z
Vancouver
Fouad A, Mandour M, Tomoum MO, Lasheen RM. Effectiveness of bisphosphonate for alleviating tinnitus associated with otosclerosis: a prospective case–control study. European Archives of Oto-Rhino-Laryngology. 2025. doi:10.1007/s00405-024-08935-z
BibTeX
@article{Fouad2025,
author = {Fouad, Ayman and Mandour, Mahmoud and Tomoum, Mohamed Osama and Lasheen, Reham Mamdouh},
title = {Effectiveness of bisphosphonate for alleviating tinnitus associated with otosclerosis: a prospective case–control study},
journal = {European Archives of Oto-Rhino-Laryngology},
year = {2025},
doi = {10.1007/s00405-024-08935-z}
}
EUVIMED